4//SEC Filing
Clements Ian 4
Accession 0001209191-19-049092
CIK 0001759425other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 7:19 PM ET
Size
6.9 KB
Accession
0001209191-19-049092
Insider Transaction Report
Form 4
Clements Ian
SVP Finance & Communications
Transactions
- Purchase
Common Stock
2019-09-06$11.07/sh+1,801$19,937→ 1,801 total - Purchase
Common Stock
2019-09-06$11.87/sh+2,199$26,102→ 4,000 total
Footnotes (2)
- [F1]The weighted average purchase price for the transaction reported was $11.07, and the range of prices were between $10.70 and $11.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]The weighted average purchase price for the transaction reported was $11.87, and the range of prices were between $11.77 and $11.8799. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001780080
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 7:19 PM ET
- Size
- 6.9 KB